LEADER 01664nam 2200385 n 450 001 996392221303316 005 20200824120603.0 035 $a(CKB)1000000000676620 035 $a(EEBO)2240929197 035 $a(UnM)9959471100971 035 $a(EXLCZ)991000000000676620 100 $a20790322d1709 uh 101 0 $aeng 135 $aurbn||||a|bb| 200 10$aBy the Queen, a proclamation$b[electronic resource] $eAnne R. Whereas our royal father, King James the Second, did by his letters patents under the Great Seal of England ... grant to certain persons therein names, the liberty of holding a fair .. 210 $aLondon $cprinted by Charles Bill, and the executrix of Thomas Newcomb, deceas'd; printers to the Queens most excellent Majesty$d1709 215 $a1 sheet ([1] p.) 300 $a"Given at our court at St. James's, this twenty eighth day of April, 1709.". 300 $aProhibiting the use of booths or stalls at the May-fair in Great Brookfield for gaming, puppet shows or musical entertainment, etc. 300 $aSteele notation: Arms 164 His and the. No press figure. Unpriced. 300 $aReproduction of original in the British Library. 330 $aeebo-0018 606 $aFairs$zGreat Britain$vEarly works to 1800 607 $aGreat Britain$xHistory$yAnne, 1702-1714$vEarly works to 1800 615 0$aFairs 701 $aAnne$cQueen of Great Britain,$f1665-1714.$01000904 801 0$bUk-ES 801 1$bUk-ES 801 2$bCu-RivES 801 2$bCStRLIN 801 2$bCu-RivES 906 $aBOOK 912 $a996392221303316 996 $aBy the Queen, a proclamation$92306911 997 $aUNISA LEADER 03012nam 2200577Ia 450 001 9910777641003321 005 20230828220704.0 010 $a0-309-18054-6 010 $a1-280-50667-9 010 $a9786610506675 010 $a0-309-65577-3 035 $a(CKB)1000000000465560 035 $a(EBL)3378103 035 $a(SSID)ssj0000137676 035 $a(PQKBManifestationID)11158795 035 $a(PQKBTitleCode)TC0000137676 035 $a(PQKBWorkID)10088602 035 $a(PQKB)10195975 035 $a(MiAaPQ)EBC3378103 035 $a(Au-PeEL)EBL3378103 035 $a(CaPaEBR)ebr10132071 035 $a(CaONFJC)MIL50667 035 $a(OCoLC)923275635 035 $a(EXLCZ)991000000000465560 100 $a20060809d2006 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aDeveloping a national registry of pharmacologic and biologic clinical trials$b[electronic resource] $eworkshop report /$fCommittee on Clinical Trial Registries, Board on Health Sciences Policy, Institute of Medicine of the National Academies 210 $aWashington, D.C. $cNational Academies Press$dc2006 215 $a1 online resource (124 p.) 300 $aDescription based upon print version of record. 311 $a0-309-10078-X 320 $aIncludes bibliographical references (p. 47-48). 327 $a""Front Matter""; ""Independent Report Reviewers ""; ""Foreword ""; ""Preface ""; ""Contents ""; ""List of Tables ""; ""1 Summary ""; ""2 The Need for Clinical Trial Registries ""; ""3 Current Registry Activities ""; ""4 Content of a Clinical Trial Registry ""; ""5 Implementation Issues ""; ""6 Conclusion and Next Steps ""; ""References ""; ""APPENDIXES""; ""A Participants and Invited Experts Between December 1, 2004, and June 27, 2005 ""; ""B Workshop Agenda, Speakers, Panelists, and Participants: June 27, 2005 "" 327 $a""C Section 113 of the Food and Drug Administration Modernization Act of 1997 and Guidance for Industry: Information Programs on Clinical Trials for Serious or Life- Threatening Diseases and Conditions. U.S. Department of Health and Human Services.""""D Published Journal Editorials ""; ""E Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases""; ""F Illustrative Data Fields for the Results Summary (based on ICH E3 template) ""; ""G Biographical Sketches of Committee Members "" 606 $aClinical trials$zUnited States 606 $aClinical medicine$xResearch 615 0$aClinical trials 615 0$aClinical medicine$xResearch. 676 $a615.5072 712 02$aInstitute of Medicine (U.S.).$bCommittee on Clinical Trial Registries. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910777641003321 996 $aDeveloping a national registry of pharmacologic and biologic clinical trials$93830700 997 $aUNINA